Insights & News

We are excited to announce that Triangle Healthcare Advisors has been awarded Healthcare/Life Sciences Deal of the Year ($100M–$1B) at the 24th Annual M&A Advisor Awards (The M&A Advisor) on November 19, 2025!

This recognition reflects the strength of our team, our deep sector expertise, and the trust our clients place in us to guide them through the most meaningful transactions of their careers.

A sincere thank you to our clients, partners, and the M&A Advisor judging panel. We’re honored to be recognized among the top performers in the industry and remain committed to delivering exceptional outcomes.

If you’re exploring strategic options, considering a sale, or simply want to understand the current market, our team would be happy to connect. Reach out anytime to Joe Monahan or Sam Stout to start the conversation.  

 We are excited to announce that Triangle Healthcare Advisors has been selected as a Finalist for the 24th Annual M&A Advisors Awards in four major categories:

Investment Bank of the Year – Niche Focus
Healthcare/Life Sciences Deal of the Year ($100M–$1B)
M&A Deal of the Year ($100M–$250M)
Corporate/Strategic Deal of the Year ($100M–$250M)

Being recognized among the industry’s top performers is a testament to our team’s dedication, the trust of our clients, and our continued focus on delivering exceptional results.

Thank you to our partners, clients, and colleagues who make this work possible. We’re honored to be included and look forward to the awards ceremony. 

https://acuservecorp.com/acu-serve-merges-with-pinnacle-to-create-best-in-class-infusion-solution/

https://acuservecorp.com/acu-serve-announces-acquisition-of-tanyr-expanding-leadership-in-rcm-market/

https://www.palmettoinfusion.com/palmetto-infusion-and-iv-care-options-join-forces-to-expand-access-to-infusion-therapy-across-georgia/

https://www.hmenews.com/article/option-care-prioritizes-practitioner-model